Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 16 , ISSUE 4 ( October, 2012 ) > List of Articles

CASE REPORT

Severe suicidal digoxin toxicity managed with resin hemoperfusion: A case report

Manish Gupta, Omender Singh, Alka Bhasin, Archana Chaturvedi

Keywords : Atrioventricular block, digoxin toxicity, resin hemoperfusion

Citation Information : Gupta M, Singh O, Bhasin A, Chaturvedi A. Severe suicidal digoxin toxicity managed with resin hemoperfusion: A case report. Indian J Crit Care Med 2012; 16 (4):231-233.

DOI: 10.4103/0972-5229.106511

License: CC BY-ND 3.0

Published Online: 01-10-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Owing to its wide and easy availability, digoxin has got a significant abuse potential and may be used for suicidal purposes. Digoxin-specific antibody (Fab) fragments have become the mainstay of therapy for severe digoxin toxicity and have significantly helped in reducing mortality. However, due to its high cost and limited availability alternative measures may need to be used to manage severe intoxications especially in countries like India, where Fab fragments are unavailable. Here, we present a case of a young female who presented to our casualty with alleged history of consumption of 17.5 mg of digoxin tablets. After admission to ICU, she developed atrioventricular blocks with hemodynamic instability which had to be managed with temporary pacemaker. Her serum digoxin levels were high (12.63 ng/ml) and in the absence of Fab fragments, resin hemoperfusion was done which drastically reduced the serum digoxin levels and reverted the symptoms.


PDF Share
  1. Clinical features and successful management of suicidal digoxin toxicity without use of digoxin-specific antibody (Fab) fragments–is it possible? Trop Doct 2011;41:108-10.
  2. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation 1990;81:1744-52.
  3. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. J Am Coll Cardiol 1985;5:118A-23A.
  4. Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med 1982;307:676-8.
  5. Acute massive digoxin overdose: Survival without use of digitalis-specific antibodies. Am J Emerg Med 1986;4:364-8.
  6. Digoxin specific antibody (Fab) fragments in 34 cases of severe digitalis intoxication. J Toxicol Clin Toxicol 1985;23:327-40.
  7. Digoxin overdose: Limitations of hemoperfusion and hemodialysis. JAMA 1979;242:2100-1.
  8. Digoxin toxicity in chronic renal failure: Treatment by multiple dose activated charcoal intestinal dialysis. Hum Exp Toxicol 1997;16:733-5.
  9. Hemoperfusion in the management of digoxin toxicity. JAMA 1978;240:2736-7.
  10. Massive digitoxin intoxication. Treatment by amberlite XAD 4 resin hemoperfusion. J Toxicol Clin Toxicol 1982;19:931-50.
  11. Hemoperfusion with Amberlite resin in the treatment of self-poisoning. Acta Med Scand 1980;207:455-60.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.